PHAT - Phathom Pharmaceuticals, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Phathom Pharmaceuticals, Inc.
IPO Date: October 21, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $550.94M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.63 | 3.80%
Avg Daily Range (30 D): $0.23 | 2.83%
Avg Daily Range (90 D): $0.32 | 3.23%
Institutional Daily Volume
Avg Daily Volume: .54M
Avg Daily Volume (30 D): 1.03M
Avg Daily Volume (90 D): 1.11M
Trade Size
Avg Trade Size (Sh.): 87
Avg Trade Size (Sh.) (30 D): 78
Avg Trade Size (Sh.) (90 D): 76
Institutional Trades
Total Institutional Trades: 1,161
Avg Institutional Trade: $1.44M
Avg Institutional Trade (30 D): $1.46M
Avg Institutional Trade (90 D): $1.28M
Avg Institutional Trade Volume: .11M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.41M
Avg Closing Trade (30 D): $1.4M
Avg Closing Trade (90 D): $1.44M
Avg Closing Volume: 111.48K
 
News
Sep 1, 2026 @ 12:00 PM
Phathom Pharmaceuticals to Participate in Upcoming...
Source: Na
May 1, 2026 @ 12:00 PM
Phathom Pharmaceuticals to Highlight VOQUEZNA® ...
Source: Phathom Pharmaceuticals, Inc.
Apr 13, 2026 @ 5:00 PM
Eosinophilic Esophagitis Market in the US to Grow ...
Source: Delveinsight
Jan 8, 2026 @ 1:41 PM
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100...
Source: Rishabh Mishra
Jan 8, 2026 @ 3:33 AM
Phathom Pharmaceuticals Announces Pricing of $130 ...
Source: Na
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-1.26 $-.21 $-.37
Diluted EPS $-1.26 $-.21 $-.37
Revenue $239.66M $74.27M $58.3M
Gross Profit $198.73M $59.18M $46.31M
Net Income / Loss $-99.07M $-17.58M $-30.37M
Operating Income / Loss $-40.64M $-3.97M $-15.48M
Cost of Revenue $40.93M $15.1M $12M
Net Cash Flow $32.91M
PE Ratio